Calendar
event
Ex dividend date
07 Jul 2025
calendar_clock
Next Dividend Payment
21 Jul 2025
About Quest Diagnostics Incorporated
Ticker
info
DGX
Trading on
info
NYSE
ISIN
info
US74834L1008
Industry
info
Diagnostics & Research
Sector
info
Healthcare
CEO
info
James E. Davis
Headquarters
info
500 Plaza Drive, Secaucus, NJ, United States, 07094
Employees
info
55,000
Website
info
questdiagnostics.com
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Metrics
BasicAdvanced
Market cap
info
$20B
P/E ratio
info
22.68
EPS
info
$7.91
Dividend Yield
info
1.78%
Beta
info
0.49
Forward P/E ratio
info
18.48
EBIDTA
info
$1.98B
Ex dividend date
info
2025-07-07
Price & volume
Market cap
info
$20B
Average daily volume
info
0.8M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$3.05
Dividend yield
info
1.78%
Forward dividend per share
info
$3.20
Forward dividend yield
info
1.78%
Payout ratio
info
34.10%
Valuation
P/E ratio
info
22.68
Forward P/E
info
18.48
PEG ratio
info
1.59
Trailing P/E
info
22.68
Price to sales
info
1.98
Price to book
info
2.9
Earnings
EPS
info
$7.91
EPS estimate (current quarter)
info
$2.15
EPS estimate (next quarter)
info
$2.56
EBITDA
info
$1.98B
Revenues (TTM)
info
$10.2B
Revenues per share (TTM)
info
$91.51
Technicals
Beta
info
0.49
52-week High
info
$182.38
52-week Low
info
$132.78
50-day moving average
info
$174.00
200-day moving average
info
$162.98
Short ratio
info
3.15
Short %
info
3.91%
Management effectiveness
ROE (TTM)
info
13.95%
ROA (TTM)
info
6.13%
Profit margin
info
8.83%
Gross profit margin
info
$3.36B
Operating margin
info
13.88%
Growth
Quarterly earnings growth (YoY)
info
12.80%
Quarterly revenue growth (YoY)
info
12.10%
Share stats
Outstanding Shares
info
112M
Float
info
111M
Insiders %
info
0.40%
Institutions %
info
96.13%
Analyst Insights & forecasts
info

48% Buy

52% Hold

0% Sell

Based on information from 19 analysts.

Average price target

info
$183.92
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$2.35
$2.34
0.43%
Q2 • 24Beat
$2.30
$2.26
1.77%
Q3 • 24Beat
$2.23
$2.18
2.09%
Q4 • 24Beat
$2.21
$2.15
2.78%
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$2.62B
$222M
8.47%
Q4 • 24
$2.65B
$220M
8.30%
Q1 • 25
1.18%
-0.90%
-2.06%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$16.2B
$9.26B
57.31%
Q4 • 24
$15.8B
$8.75B
55.42%
Q1 • 25
-2.20%
-5.43%
-3.30%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$464M
$-502M
$-170M
$341M
Q4 • 24
$314M
$-115M
$-561M
$197M
Q1 • 25
-32.33%
-77.09%
230.00%
-42.23%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Quest Diagnostics Incorporated share?
Collapse

Quest Diagnostics Incorporated shares are currently traded for undefined per share.

How many shares does Quest Diagnostics Incorporated have?
Collapse

Quest Diagnostics Incorporated currently has 112M shares.

Does Quest Diagnostics Incorporated pay dividends?
Collapse

Yes, Quest Diagnostics Incorporated does pay dividends.

What is Quest Diagnostics Incorporated 52 week high?
Collapse

Quest Diagnostics Incorporated 52 week high is $182.38.

What is Quest Diagnostics Incorporated 52 week low?
Collapse

Quest Diagnostics Incorporated 52 week low is $132.78.

What is the 200-day moving average of Quest Diagnostics Incorporated?
Collapse

Quest Diagnostics Incorporated 200-day moving average is $162.98.

Who is Quest Diagnostics Incorporated CEO?
Collapse

The CEO of Quest Diagnostics Incorporated is James E. Davis.

How many employees Quest Diagnostics Incorporated has?
Collapse

Quest Diagnostics Incorporated has 55,000 employees.

What is the market cap of Quest Diagnostics Incorporated?
Collapse

The market cap of Quest Diagnostics Incorporated is $20B.

What is the P/E of Quest Diagnostics Incorporated?
Collapse

The current P/E of Quest Diagnostics Incorporated is 22.68.

What is the EPS of Quest Diagnostics Incorporated?
Collapse

The EPS of Quest Diagnostics Incorporated is $7.91.

What is the PEG Ratio of Quest Diagnostics Incorporated?
Collapse

The PEG Ratio of Quest Diagnostics Incorporated is 1.59.

What do analysts say about Quest Diagnostics Incorporated?
Collapse

According to the analysts Quest Diagnostics Incorporated is considered a hold.